Overview

Clinical Outcomes and Evaluation of Lotemax 0.5% in Treatment of Ocular Inflammation Associated With Cataract Surgery

Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
Investigate the intraocular pressure(pressure inside the eye) of patients who are treated with Lotemax after undergoing cataract surgery.
Details
Lead Sponsor:
Discover Vision Centers
Toyos Clinic
Treatments:
Loteprednol Etabonate
Ophthalmic Solutions
Pharmaceutical Solutions